Bicara Therapeutics is a clinical-stage biotech company focusing on the development of bifunctional antibodies to target and modulate tumors. Our lead asset, ficerafusp alfa, uniquely combines tumor localization with modulation to enhance immune cell penetration while tackling resistance mechanisms in solid tumors, aiming to improve patient outcomes.
No jobs found. Subscribe below to get notified when we find something for you.
Searching
Companies
Want job alerts that match your preferences?
Set up job preferences →